New blood thinner tested in small chinese heart study
Knowledge-focused
Not yet recruiting
This early-stage trial will study how a single 16 mg dose of selatogrel, an injectable blood thinner, is absorbed and tolerated in 20 Chinese adults with chronic coronary syndrome. Participants will stay at a clinic for a few days and receive either selatogrel or a placebo. The g…
Phase: PHASE1 • Sponsor: Viatris Innovation GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC